STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
35 hedge funds and large institutions have $897K invested in Statera Biopharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
35
Holding in Top 10
–
Calls
$5K
Puts
–
Top Buyers
| 1 | +$417K | |
| 2 | +$43K | |
| 3 | +$15.7K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7K |
Top Sellers
| 1 | -$105K | |
| 2 | -$50K | |
| 3 | -$25.8K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$22K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$17.4K |